EASL recommendations on treatment of hepatitis C: Final update of the series ^? .

{"article_title":"EASL recommendations on treatment of hepatitis C: Final update of the series <sup>?<\/sup> .","author":"European Association for the Study of the Liver , Clinical Practice Guidelines Panel: Chair: , EASL Governing Board representative: , Panel members:","journal_title":"Journal of hepatology","issn":"1600-0641 ; Electronic","isbn":"","publication_date":"20201101","volume":"73","issue":"5","first_page":"1170","page_count":"49","accession_number":"32956768","doi":"10.1016\/j.jhep.2020.08.018","publisher":"Elsevier","doctype":"Practice Guideline; Journal Article","subjects":"Heptalogy ","interest_area":["Gastroenterology"," Internal\/Family Medicine"],"abstract":"Conflict of interest Jean-Michel Pawlotsky: Grant and research support: Abbott, Vela Diagnostics. Advisory Boards: Abbvie, Arbutus, Gilead, GlaxoSmithKline, Merck, Regulus and Siemens Healthcare. Speaking and teaching: Abbvie and Gilead. Alessio Aghemo: Grant and research support: Abbvie and Gilead. Advisory Boards: Abbvie, Alfasigma, Gilead, Intercept, Merck and Mylan. Speaking and teaching: Abbvie, Alfasigma, Gilead, Intercept, Merck and Mylan. Marina Berenguer: Grant and research support: Gilead. Advisory Boards: Abbvie, Gilead and Intercept. Speaking and teaching: Abbvie, Astellas, Intercept and Novartis. Olav Dalgard: Grant and research support: Abbvie, Gilead and Merck. Advisory Boards: Gilead and Merck. Speaking and teaching: Abbvie and Merck. Geoffrey Dusheiko: Grant and research support: Abbott, Cepheid, Gilead and Merck. Advisory Boards: Abbott, Arbutus, Gilead. Safety monitoring boards: Enanta and Janssen. Speaking and teaching: Cepheid and Gilead. Fiona Marra: Grant and research support: Abbvie and Gilead. Advisory Boards: Abbvie, Gilead, Merck and Viiv. Speaking and teaching: Abbvie, Gilead and Merck. Francesco Negro: Grant and research support: Abbvie and Gilead. Advisory Boards: Abbvie, Gilead and Merck. Speaking and teaching: Abbvie and Gilead. Massimo Puoti: Grant and research support: Cepheid, Gilead, Merck and Viiv. Advisory Boards: Abbvie, Bristol-Myers Squibb, Gilead, Merck and Viiv. Speaking and teaching: Abbvie, Beckman-Coulter, Bristol-Myers Squibb, Correvio, Gilead, Janssen, Merck, Nordic Pharma, Pfizer, Roche, Roche Diagnostics and Viiv. Heiner Wedemeyer: Grant and research support: Abbott, Abbvie, Bristol-Myers Squibb, Gilead, Novartis and Roche Diagnostics. Advisory Boards: Abbott, Abbvie, Bayer, Bristol-Myers Squibb, Eiger, Gilead, Intercept, Janssen, Merck, Myr GmbH, Novartis and Roche Diagnostics. Speaking and teaching: Abbott, Abbvie, Bristol-Myers Squibb, Falk Foundation, Gilead, Novartis, Roche Diagnostics and Siemens. Please refer to the accompanying ICMJE disclosure forms for further details.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=32956768&authtype=shib&custid=ns346513"}